Common use of IMP Clause in Contracts

IMP. For Investigational Medicinal Product. A pharmaceutical form of an active substance or placebo being tested or used as a reference in a clinical trial, including a product with a marketing authorisation when used or assembled (formulated or packaged) in a way different from the authorised form, or when used for an unauthorised indication, or when used to gain further information about the authorised form

Appears in 2 contracts

Sources: Quality Agreement (Gensight Biologics), Quality Agreement (Gensight Biologics)